Commercialization & investment in biotechnology are key forces transforming laboratory discoveries into real-world applications that benefit health, industry, and the environment. This domain bridges the gap between research innovation and market readiness, involving intellectual property strategies, regulatory navigation, and business model development. Investors, venture capitalists, and corporate partners play a crucial role in funding early-stage biotech startups, clinical trials, and manufacturing scale-up. Commercialization & Investment in Biotechnology also include public-private partnerships and technology transfer offices that support licensing and entrepreneurship. As competition intensifies, strategic alliances and investor confidence hinge on strong scientific validation, scalable platforms, and clear regulatory pathways. This process not only accelerates product development but ensures that scientific breakthroughs reach patients, consumers, and industries worldwide.